<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal">Peter,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Two months ago, that is, on January 27, we started work at Elsevier to make available as much as possible of the scholarly literature on coronavirus research easily discoverable and freely accessible.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">At 1science, we created the Coronavirus Research Hub:<br>
<br>
<a href="https://coronavirus.1science.com/search">https://coronavirus.1science.com/search</a><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">This hub contains more than 36,000 bibliographic records from scholarly journals on coronavirus research which we are harvesting from all around the world. Like all papers in 1findr, they cover every fields of knowledge and all language.
We’re working continuously to expand the collection yet we are concerned to keep it a tight collection to make the literature as relevant as possible.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Of these, a full 20,000 articles are freely downloadable. Everyone concerned at Elsevier from the top to the bottom, and the bottom to the top has work to make all Elsevier coronavirus-related literature freely available. Elsevier is not
alone and many other publishers have unlocked their articles.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">If we can help further, please let us know, we have been on it for two months and we continue to evaluate options to help the research community.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Yours sincerely<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span lang="FR-CA">Éric<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="FR-CA"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-bottom:6.0pt;line-height:16.0pt"><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">Eric Archambault
</span></b><span lang="FR-CA" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:14.0pt"><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">Vice-Président |
</span></b><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:#FF9900">ELSEVIER</span></b><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray"> | Vice-President</span></b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">
</span><span lang="FR-CA" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="margin-bottom:6.0pt;line-height:14.0pt"><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">Directeur général |
</span></b><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:#0563C1">1science</span></b><b><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray"> | General Manager</span></b><span lang="FR-CA" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:14.0pt"><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">3863 St-Laurent, suite 206 | Montréal, QC, Canada | H2W 1Y1</span><span lang="FR-CA" style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height:14.0pt"><a href="mailto:e.archambault@elsevier.com"><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">e.archambault@elsevier.com</span></a><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span lang="FR-CA" style="font-size:10.0pt;font-family:"Helvetica",sans-serif;color:gray">+1.438.356.4619</span><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><a href="https://orcid.org/0000-0002-4422-1054"><span style="color:windowtext;text-decoration:none"><img border="0" width="25" height="25" style="width:.2604in;height:.2604in" id="Picture_x0020_6" src="cid:image001.png@01D60699.FE45D280"></span></a><span lang="FR-CA">
</span><a href="https://www.linkedin.com/in/ericarchambault"><span lang="FR-CA" style="color:windowtext;position:relative;top:-1.0pt;mso-text-raise:1.0pt;text-decoration:none"><img border="0" width="23" height="23" style="width:.2395in;height:.2395in" id="Picture_x0020_5" src="cid:image002.png@01D60699.FE45D280"></span></a><span lang="FR-CA" style="mso-fareast-language:EN-CA"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>From:</b> goal-bounces@eprints.org <goal-bounces@eprints.org>
<b>On Behalf Of </b>Peter Murray-Rust<br>
<b>Sent:</b> March 30, 2020 12:45 PM<br>
<b>To:</b> Global Open Access List (Successor of AmSci) <goal@eprints.org><br>
<b>Subject:</b> [GOAL] COVID-19 and access to knowledge<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<div>
<div>
<p class="MsoNormal">We've launched a site <a href="https://github.com/petermr/openVirus">
https://github.com/petermr/openVirus</a> to search the whole open literature for content which could help tackle the pandemic. We're looking for volunteers (tech, biblio/library, documenters to help).<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal">Background<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">=========<o:p></o:p></p>
</div>
<p class="MsoNormal">It's now clear that knowledge is one of the key tools in tackling this COVID-19 epidemic, and also that citizens across the world are desperate for knowledge. To address this some organizations are releasing restrictions on all IP as long
as the epidemic lasts + 1 year.<br>
<a href="https://opencovidpledge.org/" target="_blank">https://opencovidpledge.org/</a><o:p></o:p></p>
<div>
<p class="MsoNormal"><br>
>>>><span style="font-size:12.0pt;font-family:"Georgia",serif;color:#1A1A1A">Immediate action is required to halt the COVID-19 Pandemic and treat those it has affected. It is a practical and moral imperative that every tool we have at our disposal be applied
to develop and deploy technologies on a massive scale without impediment.</span><o:p></o:p></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:21.0pt;margin-left:0cm">
<b><span style="font-size:12.0pt;font-family:"Georgia",serif;color:#1A1A1A">We therefore pledge to make all intellectual property under our control available to any group or individual for use in ending the COVID-19 pandemic and minimizing the impact of the
disease, free of charge and without encumbrances.</span></b><span style="font-size:12.0pt;font-family:"Georgia",serif;color:#1A1A1A"><o:p></o:p></span></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:21.0pt;margin-left:0cm;box-sizing:inherit">
<span style="font-size:12.0pt;font-family:"Georgia",serif;color:#1A1A1A">We will implement this pledge expeditiously in accordance with the rules and regulations under which we operate.<o:p></o:p></span></p>
<p class="MsoNormal"><<<<<o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal"><br>
The COVID-19 outbreak has drawn a minimal response from Scholarly publishing, both commercial and academic (e.g. repositories). One publisher, The Royal Society, has made ALL its publications freely accessible without restriction. This is the minimum that makes
any difference.<br>
The only other response I know of is CORD-19 dataset (<a href="https://cset.georgetown.edu/covid-19-open-research-dataset-cord-19/">https://cset.georgetown.edu/covid-19-open-research-dataset-cord-19/</a>) <br>
>>>><br>
<br>
<o:p></o:p></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;background:#FBFCFD">
<span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#333333">CORD-19 contains 29,000 full-text articles with a wealth of information about the novel coronavirus (SARS-CoV-2), the associated illness COVID-19, and related viruses. The collection
will be updated as new research is published in peer-reviewed publications and archival services like <a href="https://www.biorxiv.org/"><span style="color:#045089">bioRxiv</span></a>, <a href="https://www.medrxiv.org/"><span style="color:#045089">medRxiv</span></a>,
and others.<o:p></o:p></span></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm;background:#FBFCFD;box-sizing:border-box;line-height:inherit">
<span style="font-size:12.0pt;font-family:"Helvetica",sans-serif;color:#333333">At the request of the White House Office of Science and Technology Policy, CSET leads this effort in partnership with the Allen Institute for AI, Chan Zuckerberg Initiative, Microsoft
Research and the National Library of Medicine of the National Institutes of Health. <br>
<<<<<o:p></o:p></span></p>
<p class="MsoNormal">I have worked with this dataset and had helpful discussions with Allen AI. But I believe this response is minimal and can be only used by a very small proportion of the world. (I have no criticism of Allen AI, but I have a major criticism
of the scholarly publishing industry).<br>
<br>
This dataset (29 K) is a minute fraction of scholarly publication relevant to epidemics, between 0.1-1% . Half of it is public anyway in Europe/PMC and *rxiv so the amount contributed by publishers is even less. It assumes that (a) the publishers know what
people want (they don't) and (b) that the only people who need to get help are datamining AI academics. The data set is not readable by humans (the papers have been cast into JSON and the metadata removed into a separate CSV file). <br>
<br>
The terms "COVID", "SARS", "coronavirus" only reach a small amount of the literature. I'm on a Cambridge Slack where my colleagues are discussing many different aspects of tackling the epidemic. Here are some:<br>
* aerosols<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">* communications<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">* early detection<br>
* epidemic modelling<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">* law<br>
* masks<br>
* molecular modelling<br>
* strategy<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal">* surfaces<br>
* ventilators<br>
<br>
None of these will be in CORD-19.<br>
<br>
It's clear that some strategies depend heavily on human behaviour and political systems. We need papers on history, law, psychology, economics, literature, maths, statistics, education, politics ...<br>
... in fact everything<br>
<br>
Every subject researched in University is relevant to this fight. <br>
And the majority of citizens will be able to understand and use a large amount of the scholarly literature. You don't need to know quantum mechanics to read papers on how previous epidemics have been controlled.<br>
<br>
Humans now must have a basic right to read any publicly funded research without restriction. Charging them 35-50 USD to read a single paper for one day is an insult. CEO's trumpeting what a great contribution CORD-19 is is unbearably arrogant. People are losing
their livelihoods and lives, yet they are being charged exorbitant amounts to read about how to stay alive.<br>
<br>
"food rationing" is a possible strategy in compliance. I've searched Elsevier and Taylor and Francis for this and of the top 20/25 hits there is ZERO access to citizens, even for papers 50 years old. It's time we started thinking about READERS, not authors.<br>
<br>
It's also critical that we use machines to read the ALL literature as it is published - perhaps 10K / day. And also theses. It's not a huge task, it's just horribly messy because we don't have tradition of wanting the output to be read or used. (If we had,
the Ebola outbreak prediction would have been made public many years ago).<br>
<br>
The only modern way to use the fruits of public scholarship are:<br>
* create all material openly<br>
* with a semantic version<br>
* review as necessary in public<br>
* remove any access barriers to authoring or reading or re-using<br>
* use machines to process all material and index it with a single point of access. (Individual publishers with own brands are a massive friction in the system. Individual university repositories are massive friction. )<br>
* annotate, split, combine, compute. The human/machine readership should be the judge of what's useful and needed.<br>
* pay for service, not rent/ownership. The preprint servers have shown that the costs are very low. Latin America has shown that the costs are very low.<br>
<br>
This means that publishers must adapt or die. Other industries are doing that - planes, manufacturing , food, ... People are dying. There is no longer a right to make money by restricting access to knowledge (Paywalls, lawyers, Glass screens, etc.). Publishers
- if they are needed at all - must put the dissemination of public knowledge at the top of their mission.<br>
<br>
And if you've read this polemic this far, and have something to contribute,<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><a href="https://github.com/petermr/openVirus">https://github.com/petermr/openVirus</a><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><br>
<br>
<br>
<br>
<br>
<br clear="all">
<o:p></o:p></p>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p class="MsoNormal">-- <o:p></o:p></p>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal">"I always retain copyright in my papers, and nothing in any contract I sign with any publisher will override that fact. You should do the same".<o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<div>
<p class="MsoNormal">Peter Murray-Rust<br>
Reader Emeritus in Molecular Informatics<br>
Unilever Centre, Dept. Of Chemistry<br>
University of Cambridge<br>
CB2 1EW, UK<br>
+44-1223-763069<o:p></o:p></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>